"In this trial, children with severe atopic dermatitis
had uncontrolled disease covering, on average, nearly 60% of their skin.
The Phase 3, randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of Dupixent combined with TCS in children with severe atopic dermatitis
. The trial enrolled 367 patients aged 6 to 11 years with severe atopic dermatitis
whose disease could not be adequately controlled with topical medications.
The IL-4 and IL-13 are key drivers of the type 2 inflammation that plays a major role in atopic dermatitis
, as well as asthma and chronic rhinosinusitis with nasal polyposis.
in US adults: epidemiology, association with marital status, and atopy.
This article presents our personal experience with omalizumab in the treatment of two patients with severe atopic dermatitis
and extremely elevated IgE levels.
The Economic Burden Associated With Time to Therapy Escalation for Patients With Atopic Dermatitis
Uncontrolled With Topical Therapies
(AD) is a chronic, relapsing inflammatory skin disorder which is characterized by itchy papules, vesicles, excoriations and lichenification.1 Genetic, environmental, skin barrier defects and immunological factors are involved in its pathogenesis.2,3 Atopic dermatitis
tends to be a chronic disease with relapsing course so that long-term treatment is usually required to control the flare ups.4 Treatment of atopic dermatitis
can be divided into topical and systemic therapy.
Therapeutic patient education has been applied to a variety of conditions and is now being studied in atopic dermatitis
. Food allergy and infection represent common comorbidities in patients with atopic dermatitis
Inclusion criteria : Suspected dogs were subjected to following diagnostic criteria of Canine Atopic Dermatitis
based on Favrot et al.
"It's really a candidate for not only atopic dermatitis
but for psoriasis," she said at the annual meeting of the Pacific Dermatologic Association.
But now, a better understanding of the underlying causes of atopic dermatitis
has opened the door to a targeted treatment that can address a critical factor behind atopic dermatitis
is one of the most common allergic skin diseases in dogs and cats.